Search results
-
Dr Ali Amin Al Olama
My research has focused on discovery of genetic risk factors of prostate cancer ...
-
Dr Ashwin Seshia
One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems ...
-
Professor Antonis Antoniou
My main research interest is the development and application of statistical modelling ... tools which are used in clinical practice. I have a research group of 10 which focuses on two broad areas: - the development and ...
-
Dr Adrien Hallou
... PhD in Biophysics at the University of Cambridge. I am now a Research Fellow at Darwin College and a Herchel Smith Research Fellow in the group of Professor Benjamin Simons, where my work ...
-
Dr Adrian Ionescu
I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, ... of contemporary experimental condensed matter physics research including spintronics, surface science, magnetism at the nanoscale and ... strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these ...
-
Dr Aisling Redmond
... field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), partially ... Scientific Associate in Dr Duncan Odom’s lab at the Cancer Research UK Cambridge Institute, analysing non-coding regions of the genome. ...
-
Dr Alexandre Kabla
My main research activities focus on the mechanical properties of soft disordered ...
-
Professor Anna Korhonen
I conduct research in computer science - in natural language processing and text mining. I have research projects which focus on biomedical text processing and mining, e.g. ... develops text mining technology for the needs of cancer research. ...
-
Mr Aman Coonar
Clinical research in thoracic cancer with emphasis on surgery. Local PI for PULMICC ...
-
Mr Amit Roshan
... with a clinical interest in early stage melanoma. My research focus is currently exploring the utility of circulating tumour DNA ...
-
Professor Brian Huntly
... of leukaemia stem cells and are examining self-renewal programmes downstream of leukaemia-associated oncogenes and a known ...
-
Dr Daniel Hodson
... to apoptosis. Rapidly changing, but tightly controlled, programmes of gene expression determine successive cell fate choices during the ...
-
Mrs Gill Kortum
... Manager for both the Paediatric Cancer and Neuro-oncology programmes in the CRUK Cambridge Centre. ...
-
Dr Hedley Carr
... across a range of drug discovery and clinical development programmes in a variety of cancer settings. ...
-
Dr Juliet Usher-Smith
... to help prevent cancer and inform stratified screening programmes. ...
-
Dr Kelly Fagan Robinson
... peoples' concerns about screening and other early detection programmes, which in turn has fostered development of insights into ...
-
Professor Ming-Qing Du
... We have been undertaking a series of research programmes to elucidate the pathology, immunophenotype, and molecular genetics ...
-
Mr Michael Simmons
... two interdisciplinary computational radiotherapy research programmes. ...
-
Dr Tim Mitchell
... FLT3 & TYK2 kinase cancer and autoimmune disease research programmes. SKIL® can also generate drug research programmes against other kinase targets. ...
-
Dr Steven Bell
I am an Epidemiologist based within the Precision Breast Cancer Institute , Department of Oncology at the University of Cambridge. At present my work utilises next-generation sequencing data alongside bioinformatic approaches to obtain insights...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...
-
Dr Ashray Gunjur
I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...
-
Professor Alan Warren
Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...
-
Dr Andrew Pierce
DNA damage and repair, oncology clinical biomarkers
-
Mr Angelos Kolias
Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...
-
Dr Antony Rix
Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...
-
Professor Tony Green
Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...
-
Professor Charlotte Coles
Charlotte Coles is Professor of Breast Cancer Clinical Oncology and NIHR Research Professor at the CRUK Cambridge Centre. Her research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising...
-
Dr Simon Cook
In terms of basic science we are interested in how protein kinase and lipid signalling pathways control cell fate decisions such as proliferation versus differentiation and survival versus death. However, these pathways are frequently de-regulated in...
-
Dr Alasdair Russell
... team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to ...
-
Mrs Catherine Atkins
Communications and Administration Manager for the Early Cancer Institute, www.earlycancer.cam.ac.uk., the UK's only Institute dedicated to research into Early Cancer. A highly multidisciplinary, collaborative ecosystem of experts is working to take...
-
Ms Fiona Morgan
We are a small, highly interactive and international research team whose passion is using new technological innovations to improve our understanding of metabolic (especially redox) processes in disease. We hope to use these findings to improve cancer...
-
Dr Kathryn Chapman
... NC3Rs, Kathryn founded and directed a new challenge-led open innovation platform, CRACK IT which increases cross-discipline and cross-sector ...
-
Dr Martin Swarbrick
... Research Campus, Cambridge, and the London Bioscience Innovation Centre, TDL comprises over 80 staff from both industrial and ...
-
Professor Sarah Bohndiek
Our passion is integrating new technological innovations into biomedical imaging that can help to improve our understanding of metabolic (especially oxygen related) processes in disease. We hope to use these findings to improve cancer patient survival,...
-
Dr Siddhartha Kar
With the support of funding from UK Research and Innovation and Cancer Research UK, the Kar group primarily studies inherited or ...
-
Mr Stephen Price
... into clinical practice and the impact that has allowing innovation lead improved patient benefit. ...
-
Professor Vincent Gnanapragasam
... The invention won the Cambridgeshire Live Business award for Innovation in 2023. He is Chief Investigator of the DIAMOND study which ...
-
Dr Andreas Bender
... related to cancer drug discovery you are very welcome to contact me to see in which way I could contribute to your project. ...
-
Dr Daniel Munoz-Espin
... people interested in joining my laboratory, please contact me directly (dm742@cam.ac.uk). ...
-
Dr Guy Blanchard
... for grant and Symposium information. Please contact me if you are considering neuroblastoma-related work. ...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Professor Adrian Liston
We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...
-
Mr Alexander Evtushenko